Al-hoshary D, Zalzala MH (2023) Assessment of Ellagic Acid Action in 5-Fluorouracil Induced Intestinal Mucositis: Assessment of Ellagic Acid Action in 5-Fluorouracil Induced Intestinal Mucositis. Iraqi J Pharm Sci (P-ISSN 1683–3597 E-ISSN 2521–3512) 32 (Suppl.): 33–41

Al-Kenany SA, Al-Shawi NN (2023) Protective Effect of Cafestol on Doxorubicin-Induced Genotoxicity in Rats. Iraqi J Pharm Sci (P-ISSN 1683–3597 E-ISSN 2521–3512) 32 (Suppl.): 16–25

Al-khfajy WS, Kathem SH, Aboddy AA, Hatem SF, Zalzala MH, Arif IS (2018) Farnesoid X Receptor Is an Exciting New Perspective Target For Treatment Of Diverse Pathological Disorders. J Pharm Sci Res 10(9):2292–2296

CAS  Google Scholar 

Atshan DA, Zalzala MH (2023) Possible protective effect of low dose of papaverine on anit induce cholestasis in rat. Iraqi J Pharm Sci (P-ISSN 1683–3597 E-ISSN 2521–3512) 32 (Suppl.): 118–26

Atshan DA, Zalzala MH (2024b) Possible protective effect of nicardipine on anit induce cholestasis in rat. Farmacia 72(1):140–48

Article  CAS  Google Scholar 

Atshan DA, Zalzala MH (2024a) Papaverine Attenuates the Progression of Alpha Naphthylisothiocyanate Induce Cholestasis in Rats. Curr Res Pharmacol Drug Disc 6:100177

Article  Google Scholar 

Barone M, Maiorano E, Ladisa R, Cuomo R, Pece A, Berloco P, Caruso ML, Valentini AM, Iolascon A, Francavilla A (2003) Influence of Ursodeoxycholate-Enriched Diet on Liver Tumor Growth in HBV Transgenic Mice. Hepatology 37(4):880–886

Article  CAS  PubMed  Google Scholar 

Begum S (2020) Hepatic Nuclear Factor 1 Alpha (HNF-1α) in Human Physiology and Molecular Medicine. Curr Mol Pharmacol 13(1):50–56

Article  CAS  PubMed  Google Scholar 

Blumberg B, Evans RM (1998) Orphan Nuclear Receptors—New Ligands and New Possibilities. Genes Dev 12(20):3149–3155

Article  CAS  PubMed  Google Scholar 

Bodin K, Bretillon L, Aden Y, Bertilsson L, Broomé U, Einarsson C, Diczfalusy U (2001) Antiepileptic Drugs Increase Plasma Levels of 4β-Hydroxycholesterolin Humans: Evidence for Involvement of Cytochrome P450 3A4. J Biol Chem 276(42):38685–38689

Article  CAS  PubMed  Google Scholar 

Boehm MF, Zhang L, Badea BA, White SK, Mais DE, Berger E, Suto CM, Goldman ME, Heyman RA (1994) Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids. J Med Chem 37(18):2930–2941

Article  CAS  PubMed  Google Scholar 

Cao P, Gan J, Sanlan Wu, Yixin Hu, Xia B, Li X, Zeng H, Cheng B, Huifan Yu, Li F (2023) Molecular Mechanisms of Hepatoprotective Effect of Tectorigenin against ANIT-Induced Cholestatic Liver Injury: Role of FXR and Nrf2 Pathways. Food Chem Toxicol 178:113914

Article  CAS  PubMed  Google Scholar 

Chen L, Wei S, Liu H, Li J, Jing M, Tong Y, Li R, Wen J, Zhan H, Zhao Y (2021) Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway. Evid-Based Complement Altern Med 2021. https://doi.org/10.1155/2021/8479868

Chiang JYL (1998) Regulation of Bile Acid Synthesis. Front Biosci-Landmark 3(4):176–193

Article  Google Scholar 

Claudel T, Staels B, Kuipers F (2005) The Farnesoid X Receptor: A Molecular Link between Bile Acid and Lipid and Glucose Metabolism. Arterioscler Thromb Vasc Biol 25(10):2020–2030

Article  CAS  PubMed  Google Scholar 

Contreras-Omaña R, Velarde-Ruiz Velasco JA, Castro-Narro GE, Trujillo-Benavides O, Zamarripa-Dorsey F, Reyes-Dorantes AA, Muñoz-Espinosa L, Aiza-Haddad I, Castillo-Barradas M, Cerda-Reyes E (2022) Approach to the Patient with Cholestasis and Jaundice Syndrome. Joint AMH, AMG, and AMEG Scientific Position Statement. Rev Gastroenterol Mex (Engl Ed) 87(1):80–88

PubMed  Google Scholar 

Corpechot C, Carrat F, Bahr A, Chrétien Y, Poupon R-E, Poupon R (2005) The Effect of Ursodeoxycholic Acid Therapy on the Natural Course of Primary Biliary Cirrhosis. Gastroenterology 128(2):297–303

Article  CAS  PubMed  Google Scholar 

Crosigani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KDR (1991) Failure of Ursodeoxycholic Acid to Prevent a Cholestatic Episode in a Patient with Benign Recurrent Intrahepatic Cholestasis: A Study of Bile Acid Metabolism. Hepatology 13(6):1076–1083. https://doi.org/10.1002/hep.1840130612

Article  Google Scholar 

Cui S, Huijian Hu, Chen An, Cui M, Pan X, Zhang P, Wang G, Wang H, Hao H (2023) SIRT1 Activation Synergizes with FXR Agonism in Hepatoprotection via Governing Nucleocytoplasmic Shuttling and Degradation of FXR. Acta Pharmaceutica Sinica B 13(2):559–576

Article  CAS  PubMed  Google Scholar 

Di Ciaula A, Garruti G, Baccetto RL, Molina-Molina E, Bonfrate L, Portincasa P, Wang DQH (2018) Bile Acid Physiology. Ann Hepatol 16(1):4–14

Google Scholar 

Dietrich CG, Ottenhoff R, de Waart DR, Oude RPJ, Elferink. (2001) Role of MRP2 and GSH in Intrahepatic Cycling of Toxins. Toxicology 167(1):73–81

Article  CAS  PubMed  Google Scholar 

Dj M (2000) The Nuclear Receptor Superfamily: The Second Decade. Cell 83:835–839

Google Scholar 

Farol LT, Hymes KB (2004) Bexarotene: A Clinical Review. Expert Rev Anticancer Ther 4(2):180–188

Article  CAS  PubMed  Google Scholar 

Fiorucci S, Zampella A, Distrutti E (2012) Development of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders. Curr Top Med Chem 12(6):605–624

Article  CAS  PubMed  Google Scholar 

Goldfarb S, Singer EJ, Popper H (1962) Experimental Cholangitis Due to Alpha-Naphthyl-Isothiocyanate (ANIT). Am J Pathol 40(6):685

CAS  PubMed  PubMed Central  Google Scholar 

Hameed HA, Hassan AF (2023) The Hepatoprotective Effect of Omega-7 Against Paracetamol-Induced Hepatotoxicity in Male Rats. Iraqi J Pharm Sci (P-ISSN 1683–3597 E-ISSN 2521–3512) 32 (3): 85–94

He L, Guo C, Peng C, Li Y (2021) Advances of Natural Activators for Nrf2 Signaling Pathway on Cholestatic Liver Injury Protection: A Review. Eur J Pharmacol 910:174447

Article  CAS  PubMed  Google Scholar 

Horn TL, Torres KEO, Naylor JM, Cwik MJ, Detrisac CJ, Kapetanovic IM, Lubet RA, Crowell JA, McCormick DL (2007) Subchronic Toxicity and Toxicogenomic Evaluation of Tamoxifen Citrate+ Bexarotene in Female Rats. Toxicol Sci 99(2):612–627

Article  CAS  PubMed  Google Scholar 

Ibrahim MA, Omran S, Ghalib NS, Al-Shawi NN (2024) The Potential Hepatoprotective Effect of Vinpocetine against Lead-Induced Inflammatory and Apoptotic Cytokines in Rats. Iraqi J Pharm Sci 33 (3): 56–62. https://doi.org/10.31351/vol33iss3pp56-62

Jin H-L, Liu X-J, Feng X-Y, Zhu W-T, Feng S-L, Cao L-P, Yuan Z-W (2023) Quercetin 7-Rhamnoside Protects against Alpha-Naphthylisothiocyanate (ANIT)-Induced in Cholestatic Hepatitis Rats by Improving Biliary Excretion and Inhibiting Inflammatory Responses. Front Pharmacol 13:1116257

Article  PubMed  PubMed Central  Google Scholar 

Jung D, Kullak-Ublick GA (2003) Hepatocyte Nuclear Factor 1α: A Key Mediator of the Effect of Bile Acids on Gene Expression. Hepatology 37(3):622–631

Article  CAS  PubMed  Google Scholar 

Khaleel RA, Zalzala MH (2023) The Ameliorating Effect of Oral Paquinimod Administration against Imiquimod Induced Psoriasis-like Inflammation in Mice. Iraqi J Pharm Sci (P-ISSN 1683–3597 E-ISSN 2521–3512) 32 (1): 92–99

Kim I, Ahn S-H, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, Gonzalez FJ (2007) Differential regulation of bile acid homeostasis by the farnesoid x receptor in liver and intestine. J Lipid Res 48(12):2664–2672

Article  CAS  PubMed  Google Scholar 

Kong Bo, Wang Li, Chiang JYL, Zhang Y, Klaassen CD, Guo GL (2012) Mechanism of tissue-specific farnesoid x receptor in suppressing the expression of genes in bile-acid synthesis in mice. Hepatology 56(3):1034–1043

Article  CAS  PubMed  Google Scholar 

Kriegermeier A, Green R (2020) Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies. Front Med 7:149

Article  Google Scholar 

Kulkarni SR, Soroka CJ, Hagey LR, Boyer JL (2016) Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis. Hepatology 64(6):2151–2164

Article  CAS  PubMed  Google Scholar 

Lane MA, Bailey SJ (2005) Role of retinoid Signalling in the adult brain. Prog Neurobiol 75(4):275–293

Article  CAS  PubMed  Google Scholar 

Lindor KD, Kowdley KV, Luketic VAC, Edwyn Harrison M, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J (2009) High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 50(3):808–814

Article  CAS  PubMed  Google Scholar 

Lopez M, Mazzanti L (1955) experimental investigations on alpha-naphthyl-iso-thiocyanate as a hyper-plastic agent of the biliary ducts in the rat. J Pathol Bacteriol 69(1):243–250

Article  CAS  PubMed  Google Scholar